Diabetes Tech Signs of life

Diabetes Tech Signs of life

Mark Twain once said, “Reports of my death have been greatly exaggerated”. Given the way shares of Dexcom, Insulet and Tandem have been performing one would be under the impression they have been given up for dead. That the analysts for once are right and that Ozempic, Wegovy and Mounjaro have put the nail in the diabetes tech coffin.

Well maybe not, maybe we’ve been right all along and while there is a perception that diabetes tech is being hurt that things really aren’t all that bad. That patients are still using their CGM’s and insulin pumps . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.